The recombinant biotinylated mannose 6-phosphate receptor homology (MRH) domain of human OS-9 (OS-9 MRH ) together with six kinds of mutated OS-9 MRH were prepared and mixed with R-phycoerythrin (PE)-labeled streptavidin to form tetramers (OS-9 MRH -SA). The PE-labeled OS-9 MRH -SA bound to HeLaS3 cells in a metal ion-independent manner through amino acid residues homologous to those participating in sugar binding of the cation-dependent mannose 6-phosphate receptor, and this binding was greatly increased by swainsonine, deoxymannojirimycin, or kifunensine treatment. N-Acetylglucosaminyltransferase I-deficient Lec1 cells, but not Lec2 or Lec8 cells, were also strongly bound by the tetramer. OS-9 MRH -SA binding to the cells was strongly inhibited by Manα1,6(Manα1,3)Manα1,6(Manα1,3)Man and Manα1,6Man. To further determine the specificity of native ligands for OS-9 MRH , frontal affinity chromatography was performed using a wide variety of 92 different oligosaccharides. We found that several Nglycans containing terminal α1,6-linked mannose in the Manα1,6(Manα1,3)Manα1,6(Manα1,3)Man structure were good ligands for OS-9 MRH , having K a values of approximately 10 4 M −1 and that trimming of either an α1,6-linked mannose from the C-arm or an α1,3-linked mannose from the B-arm abrogated binding to OS-9
Introduction
The osteosarcoma 9 (OS-9) gene was first identified as a gene frequently amplified and overexpressed in human sarcomas using a chromosome microdissection-based hybrid-selection strategy (Kimura et al. 1997 (Kimura et al. , 1998 . OS-9 protein is widely expressed in human tissues (Su et al. 1996) . Three splice variant isoforms of OS-9, comprising 667, 612, and 597 amino acids, have been reported (Kimura et al. 1998 ) and all have a mannose 6-phosphate receptor homology (MRH) domain which is homologous to the mannose 6-phosphate receptor (MPR) (Munro 2001) . Cation-independent and -dependent MPRs bind strongly to terminal mannose 6-phosphate residues presented on the Nlinked oligosaccharides of lysozomal enzymes . This phosphate group most likely promotes hydrogen bonding to the receptors, resulting in an approximate 3-4 order of magnitude difference in the K d values of mannose 6-phosphate and mannose. Three-dimensional structures of the cation-dependent (CD)-MPR extracytoplasmic domain complexed with pentamannosyl phosphate show that the CD-MPR binding site encompasses the phosphate group and 3-mannose residues (Olson et al. 1999) . Recently, we demonstrated that MRH domain of glucosidase II β subunit could bind to the α1,2-linked mannobiose structure, particularly on the Carm of high-mannose-type glycans (Hu et al. 2009 ), although it could bind to mannose 6-phosphate. Further, the sugar-binding specificity of MRH domains of human OS-9 (Hosokawa et al. 2009 ) and its yeast homolog, Yos9p (Quan et al. 2008) , was also shown by using frontal affinity chromatography and the results indicated that they could bind to terminal mannose of the C-arm of high-mannose-type glycans. The structure and specificity relationship of several MRH domains are interesting in the functions of these MRH domain-containing proteins.
In parallel, Medicherla et al. (2004) screened a Saccharomyces cerevisiae genomic deletion library for mutants defective in endoplasmic reticulum (ER) protein quality control and degradation. From this screening, Dsk2p and Rad23p were identified as proteins delivering the polyubiquitinated substrate from the trimeric Cdc48-Ufd1-Npl4p complex to the proteasome. Yos9p, which may be involved in ER-to-Golgi transport of the GPI-anchored proteins Gas1 and Mkc7 (Friedmann et al. 2002) , was also discovered as a candidate for involvement in ER-associated glycoprotein degradation (ERAD) (Buschhorn et al. 2004) . Yos9p shows homology with human OS-9 and has an additional HDEL ER-retention signal at its C-terminus. In the ERAD process, terminally misfolded or unassembled polypeptides within the ER are translocated across the ER Lectin properties of OS-9
Fig. 1. Domain structure of human OS-9 isomers and OS-9 MRH used in this study. (A) Domain structures of human OS-9 isomers (upper) and the MRH domain of OS-9 (OS-9 MRH ) used in this study (lower) . The MRH domain and biotinylation tag are indicated in black and gray, respectively. (B) Purified recombinant OS-9 MRH was electrophoresed on a 12.5% polyacrylamide gel under reducing conditions and stained with Coomassie brilliant blue (CBB). Molecular weight markers are indicated on the left. OS-9 MRH with Y120A, Q130E, H132A, R188A, E212D, and Y218F mutations was also electrophoresed as a single band under the same conditions (data not shown). These recombinant proteins were electrophoresed at the same position under nonreducing conditions (data not shown).
membrane, conjugated with ubiquitin, and targeted to the 26S proteasome for destruction in the cytoplasm. To further understand the ERAD molecular machinery, Carvalho et al. (2006) carried out studies on multiprotein complexes associated with the ER ubiquitin ligases Hrd1p and Doa10p in yeast. In the complex of membrane and soluble proteins with luminal lesions, Der1p, Yos9p, and Usa1p, as well as the E2 complex (i.e., Ubc7p, Cue1p) and Cdc48p complex (i.e., Cdc48p, Ufd1p, Npl4p, Ubx2p), were identified by affinity purification and mass spectrometric analysis to select misfolded and unassembled proteins for ERAD (Carvalho et al. 2006) . In another Yos9p purification experiment, Hrd3p, Emp47p, and Kar2p were identified as proteins forming a complex with Yos9p (Denic et al. 2006; Gauss et al. 2006) . A large number of soluble and membranebound ERAD substrates were also studied, and N-glycosylation of these substrates in Yos9p-mediated ERAD was discussed. It has been reported that Yos9p mutants with alterations in the putative sugar-binding amino acids showed a loss of ERAD function (Kim et al. 2005; Szathmary et al. 2005) . Although Yos9p is required both for release of DHFR and degradation of hemagglutinin, and forms a complex with ERAD substrates through a putative sugar-binding pocket in the MRH domain, substrate recognition persisted even when a conserved amino acid in the sugar-binding pocket was mutated or when the substrate was unglycosylated (Bhamidipati et al. 2005) . The relationship between human OS-9 and ERAD machinery has also been investigated in mammalian cells (Christianson et al. 2008) , and these studies suggest an involvement of both OS-9 and Yos9p in ERAD; however, the issue of whether substrates for OS-9-mediated ERAD require glycosylation remains controversial.
In parallel, the ER-degradation enhancing α-mannosidaselike protein (EDEM) in mammalian cells and Htm1p in Saccharomyces cerevisiae are believed to act sequentially or in concert with OS-9 to prevent secretion of misfolded glycoproteins and to deliver them to the cytosolic ubiquitin proteasome machinery (Hosokawa et al. 2001; Jakob et al. 2001) . These proteins were originally identified as proteins homologous to ER α-mannosidase I which are required for degradation of glycoproteins (Vallee et al. 2000; Herscovics 2001 ). Subsequent studies have demonstrated that EDEM3, which is soluble homolog of EDEM, was active α-mannosidase producing Man 5 GlcNAc 2 (M5), Man 6 GlcNAc 2 (M6), and Man 7 GlcNAc 2 (M7) highmannose-type sugar chains from Man 9 GlcNAc 2 (M9) species (Hirao et al. 2006) . Recently, it has been reported that yeast Htm1p had an α1,2-specific mannosidase activity to generate the M7 high-mannose-type glycans (Clerc et al. 2009 ). Hosokawa et al. (2009) Here, we investigated the several lectin properties of the MRH domain of human OS-9 (OS-9 MRH ) by flow cytometry using an R-phycoerythrin (PE)-labeled OS-9 MRH tetramer as previously described (Kawasaki et al. , 2008 Yamaguchi et al. 2007; Hu et al. 2009 ). Sugar-binding specificity was also determined precisely by frontal affinity chromatography using a wide variety of PA-labeled sugar chains. These results clearly indicate that OS-9 MRH strongly binds to the terminal α1,6-linked mannose, especially on a Manα1,6(Manα1,3)Manα1,6(Manα1,3)Man sequence in cation-independent manner, and that further trimming of the α1,6-linked or α1,3-linked mannose abolished its binding. Moreover, OS-9 was preferentially precipitated with the α1-antitrypsin variant null Hong Kong (AT NHK ), which is known to be a ERAD substrate, in a sugar-dependent manner.
Results

Preparation of a soluble OS-9
MRH -SA tetramer All three splice variant isoforms of OS-9 have a MRH domain that shares homology with the cation-independent and cationdependent mannose 6-phosphate receptors (Ghosh et al. 2003) . The MRH domain of OS-9, which corresponds to residues 81-237, was expressed in Escherichia coli with a biotinylation tag (OS-9 MRH , Figure 1A ) and purified ( Figure 1B ). OS-9 MRH was K Mikami et al.
biotinylated with the biotin ligase BirA to allow for binding to streptavidin (SA). Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) without boiling confirmed that OS-9 MRH was biotinylated because the band corresponding to the OS-9
MRH monomer shifted to a higher molecular weight after the addition of SA (data not shown). To prepare OS-9 MRH tetramers, we used an OS-9 MRH -SA complex mixed at a ratio of 4:1 (OS-9 MRH -SA). The OS-9 MRH mutants Y120A, Q130E, H132A, R188A, E212D, and Y218F were also expressed in and purified from E. coli and each ran as a single band of the appropriate size on SDS-PAGE (data not shown). The CD spectrum of each recombinant mutated OS-9 MRH was the same as that of wild-type OS-9 MRH (supplementary Figure 1) .
PE-labeled OS-9 MRH -SA binds to SW-, KIF-, and DMJ-treated HeLaS3 cells in a cation-independent manner
We had previously detected weak sugar interactions with the cargo receptors VIP36, VIPL, and ERGIC-53, by flow cytometry using PE-labeled tetramers (Kawasaki et al. , 2008 Yamaguchi et al. 2007) . For this study, we followed the same approach using OS-9
MRH . OS-9 MRH was complexed with PE-labeled SA (PE-labeled OS-9 MRH -SA) and incubated with HeLaS3 cells to determine whether OS-9
MRH could bind to the sugar chains displayed on the surface of these cells. One of the mannose 6-phosphate receptors binds to sugars in a divalent cation-dependent manner. Thus, we performed the binding experiment in the presence of 1 mM CaCl 2 . Targeted glycans were prepared for the binding assay by treating HeLaS3 cells with one of three α-mannosidase inhibitors to induce the formation of different glycan patterns on the cell surface. Cells treated with the ER α-mannosidase I inhibitors deoxymannojirimycin (DMJ) or kifunensine (KIF) accumulated Man 9 GlcNAc 2 (M9) and Man 8 GlcNAc 2 (M8) , while cells treated with swainsonine (SW), which inhibits Golgi α-mannosidase II, formed hybrid-type N-glycans (Tulsiani et al. 1982) . As shown in Figure 2A , we found that PE-labeled OS-9 MRH -SA showed a low level of binding to HeLaS3 cells. In contrast, the binding of PE-labeled OS-9 MRH -SA increased 10-to 30-fold when HeLaS3 cells were preincubated with SW, KIF, or DMJ. We also tested binding of PE-labeled OS-9 MRH -SA to CHO cells and their lectin-resistant variants Lec1, Lec2, and Lec8 cells. Interestingly, specific binding of OS-9 MRH -SA to Lec1 cells was 2 orders of magnitude higher than to CHO, Lec2, or Lec8 cells ( Figure 2B ). Lec1 cells are known to be deficient in N-acetylglucosaminyltransferase I (GlcNAcT1) and rich in Man 5 GlcNAc 2 N-glycans (Chen and Stanley 2003) . These data suggest that OS-9 MRH -SA preferentially binds to high-mannosetype glycans, especially those of smaller molecular weight.
We next determined whether the binding of OS-9 MRH -SA to SW-treated HeLaS3 cells was dependent on any of several metal cations. As shown in Figure 3A , binding of OS-9 MRH -SA was not affected by the presence of CaCl 2 , MnCl 2 , or EDTA, and the sugar-binding activity of OS-9
MRH was found to be cation independent. The three-dimensional structure of the MRH domain of CD-MPR complexed with mannose 6-phosphate has been determined and the amino acid residues involved in cation binding were predicted based on this (Olson et al. 1999) . Based on this crystallographic analysis, sequence alignment of the MRH domains of OS-9, CD-MPR, and CI-MPR indicated that a loop involved in cation binding of CD-MPR is deleted in both CI-MPR and OS-9, which is in agreement with our finding of metal ion independence for OS-9. To further investigate the binding of OS-9 MRH -SA to HeLaS3 cells through sugar chains, we measured the effects of endo β-N-acetylglucosaminidase H (endo H) treatment on the cells. Endo H specifically cleaves high-mannose-type N-glycans from glycoproteins, and we found that endo H treatment abolished OS-9 MRH -SA binding to DMJ-and KIF-treated cells; however, binding to SWtreated cells was not so affected ( Figure 3B ). It has been reported that hybrid-type glycans are less susceptible to endo H than high-mannose-type ones (Tharentino and Maley 1975) . Because SW-treated cells are rich in hybrid-type glycans relative to high-mannose-type ones (Tulsiani et al. 1982) , a small part of hybrid-type glycans on SW-treated cells might remain to be digested, which may retain the binding ability to OS-9 MRH -SA. To further investigate sugar-binding specificity of OS-9 MRH -SA and HeLaS3 cells, we used several monosaccharides and oligosaccharides to inhibit OS-9 MRH -SA binding. As shown in Figure 4A , mannose significantly inhibited binding of OS-9 MRH -SA to HeLaS3 cells and 300 mM fucose also partially abrogated binding. The weak inhibition of fucose may be explained by the fact that rotation of the fucose by 180
• allows superimposition of its ring oxygen, 4-OH, 3-OH, and 2-OH, with the ring oxygen, 2-OH, 3-OH, and 4-OH of mannose, respectively. Although the MRH domain is defined as a domain homologous to the mannose 6-phosphate binding unit, OS-9 MRH -SA binding was not inhibited by either mannose 6-phosphate or mannose 1-phosphate at a concentration of 100 mM ( Figure 4B ). It is interesting that MRH domain of OS-9 could not bind to either mannose 6-phosphate or mannose 1-phosphate although those of glucosidase II β subunit (Hu et al. 2009 ), CD-MPR, and CI-MPR could bind to both mannose 6-phosphate and mannose 1-phosphate. We next tested the effects of three mannobioses and the branched pentamannoside (Manα1,3(Manα1,6)Manα1,6(Manα1,3)Man) on binding of OS-9 MRH -SA. 10 mM branched pentamannoside, which is indicated by the boxed area in Figure 6A , decreased binding by 5% and Manα1,6Man, whose disaccharide unit is part of the branched pentamannoside, also significantly inhibited binding, whereas Manα1,2Man and Manα1,3Man did not prevent binding even at 30 mM ( Figure 4C ). Because GlcNAc 1 Man 5 GlcNAc 2 hybrid-type and Man 5 GlcNAc 2 highmannose-type N-glycans with a branched pentamannose structure are the dominant glycans in SW-treated HeLaS3 cells and Lec1 cells, respectively, this type of branched pentamannose structure may be a determinant of OS-9 MRH domain binding.
Binding of PE-labeled OS-9
MRH mutants, and amino acid residues involved in sugar binding The three-dimensional structure of the extracytoplasmic domain of the CD-MPR complexed with mannose 6-phosphate revealed the precise amino acid residues involved in sugar binding (Olson et al. 1999) . Based on the homology between the CD-MPR and the MRH domain of OS-9, the amino acid residues expected to bind to sugars are Tyr120, Gln130, His132, Arg188, Glu212, and Tyr218. We prepared OS-9
MRH mutants with one of each of these amino acids substituted with Ala, Glu, Ala, Ala, Asp, or Phe by site-directed mutagenesis, expressed the mutants in E. coli cells, and then purified them to run as a single band on SDS-PAGE (data not shown). The binding of each mutated OS-9
MRH -SA to SW-treated HeLaS3 cells was measured at concentrations of 1, 3, 10, 30, and 100 μg/mL ( Figure 5 ). The OS-9 MRH mutants H132A, R188A, E212D, and Y218F did not bind to cells even at a concentration of 100 μg/mL. The Q130E mutant showed low levels of binding to cells only at 100 μg/mL. The Y120A mutant showed half as much binding to cells as wild-type OS-9 MRH at a concentration of 100 μg/mL but it did not bind cells at lower concentrations. These results confirm that these amino acid residues, which were predicted to bind to sugars based on CD-MPR homology, are possibly involved in sugar binding, although the relative contribution of each amino acid to binding appears to vary.
Frontal affinity chromatography (FAC)
An inhibition experiment showed that OS-9 MRH exhibits the strongest affinity for branched pentamannoside. To identify . OS-9 MRH binds to sugars via a putative sugar-binding site. HeLaS3 cells treated with 2 μg/mL SW for 20 h were incubated with 3 μg/mL of PE-labeled OS-9 MRH (WT, open squares), OS-9 MRH with a Y120A mutation (filled triangles), Q130E mutation (filled squares), or R188A mutation (open circles), and were analyzed by flow cytometry. The binding of each OS-9 MRH mutant with H132A, E212D, and Y218F mutation, respectively, was similar to the binding of OS-9 MRH with a R188A mutation (data not shown). Results are expressed as the mean and SD of three independent experiments. native ligands of OS-9 in the cells, we then analyzed the specific structural requirements for tight binding to OS-9 MRH using frontal affinity chromatography (FAC). FAC is widely used to determine the sugar-binding specificity of lectins (Tateno et al. 2007 ). In our experiment, recombinant OS-9 MRH and OS-9 MRH Y120A were coupled with NHS-activated Sepharose beads at a concentration of 4.0 and 2.2 mg/mL gel, respectively, and a wide variety of 92 different pNP-or PA-labeled oligosaccharides (supplementary Figure 2A) were applied to both OS-9 MRHand OS-9 MRH Y120A-immobilized columns. The K a values of each individual oligosaccharide were estimated from their retardation volumes and the K a values of OS-9 MRH to several representative high-mannose-and hybrid-type N-glycans are shown in Figure 7 . The K a values of all 92 kinds of oligosaccharides are shown in supplementary Figure 2B and 2C. M9 and G1M9 oligosaccharides did not show any detectable affinity for immobilized OS-9 MRH , and M8A and M8B oligosaccharides with α1,2Man-deleted A-and B-arms, respectively, also showed no apparent affinity (Figures 6B, 7) . In contrast, M8C with an α1,2Man-deleted C-arm showed high affinity for OS-9
MRH with a K a value of 1.3 × 10 4 M −1 (Figures 6B, 7) . These results were in good agreement with a recent report by Hosokawa et al. (2009) . In addition, M7A and M7B with α1,2Man-deleted Carms were also high affinity ligands for OS-9 MRH , whereas M7C having an intact C-arm did not show any detectable interaction with OS-9
MRH . Other high-mannose-and hybrid-type oligosaccharides with α1,2Man-deleted C-arms (M6, M6iso, M5, M4, Hy1, GHy0, and SGHy0) were also found to have high K a values ranging from 1.35 × 10 4 M −1 to 2.0 × 10 3 M −1 (Figure 7) whereas all of the complex-type N-glycans tested in this study, including smaller di-and oligosaccharides, showed no interaction with OS-9 MRH (supplementary Figure 2B) . Interestingly, further trimming of the terminal α1,6-linked mannose from the C-arm (M3, M2, and Hy1-M ) or trimming of the α1,3-linked mannose from the B-arm (Hy1-M) abrogated binding to OS-9 MRH (Figure 7) . Although M3 high-mannose-type
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glycan has α1,6-linked mannose on the C-arm, it could not bind to human OS-9, whose result was different from that of yeast homolog Yos9p (Quan et al. 2008) . FAC analysis of these oligosaccharides indicated that hydrolysis of the α1,2-linked mannose in the C-arm triggers significant binding to OS-9 and that further N-glycan processing, which causes hydrolysis of the branched pentamannosyl core of high-mannose-and hybridtype oligosaccharides and produces a complex-type oligosaccharide, abrogates interaction with OS-9. We also performed FAC analysis using a sugar-binding-defective OS-9 MRH Y120A-immobilized column with a concentration of 2.2 mg/mL gel. We found that M5, M6, M6iso, M7B, and M8C showed very weak interaction with OS-9 MRH Y120A, and that their K a values were approximately 20-fold lower than those of wild-type OS-9 MRH (supplementary Figure 2C) .
Coprecipitation of α1-antitrypsin variant null Hong Kong with FLAG-tagged OS-9 or its mutant R188A in 293T cells Human α1-antitrypsin variant null
Hong Kong (AT NHK ) is known to be a good substrate for ERAD (Sifers et al. 1988 ). Both wild-type α1-antitrypsin (AT, 394 amino acids) and AT NHK (333 amino acids) have three N-linked sugar chains in their peptide backbones. AT and/or AT NHK were expressed in 293T cells together with FLAG-tagged OS-9 (isoform 1 in Figure 1A ) or its mutant OS-9 R188A . Expression levels were similar for all proteins, as confirmed by Western blotting followed by staining with anti-AT ( Figure 8A ) and anti-FLAG (data not shown) monoclonal antibodies. Although the anti-AT antibody we used reacts with both AT and AT NHK , AT NHK could be easily distinguished from AT by its lower molecular weight. The same cell lysates were then subjected to immunoprecipitation with OS-9 using an anti-FLAG antibody. The precipitates obtained were electrophoresed, blotted on a membrane, and then stained with an anti-AT monoclonal antibody. The same amount of FLAG-tagged OS-9 was precipitated from each transfected cell lysate, which was confirmed by immunostaining of the precipitates with an anti-FLAG monoclonal antibody ( Figure 8B ). Interestingly, AT NHK , but not wild-type AT, was significantly co-precipitated with FLAG-tagged OS-9 from the lysate of cells that had been transfected with AT or AT NHK and FLAG-tagged OS-9 ( Figure 8C, lanes 2 and 3) . This result was confirmed when lysates from AT, AT NHK , and FLAG-tagged OS-9 coexpressing cells ( Figure 8C , lane 4) were tested under the same conditions. This result clearly indicates that OS-9 preferentially interacts with the ERAD substrate AT NHK . In our experiment using lysate from both AT and AT NHK -expressing cells, a faint band corresponding to AT was also precipitated with OS-9. This finding may be explained by the fact that expression of AT NHK may cause the expression of ER stress-induced mannosidase(s), which enhances the trimming of mannoses on both AT and AT NHK . To assess the contribution of the sugar chains on AT NHK to the interaction of OS-9 and AT NHK , we performed an immunoprecipitation assay using lysate from cells expressing AT NHK and a sugar-binding-deficient FLAG-tagged OS-9 R188A mutant ( Figure 5 ) instead of wild-type OS-9. As shown in lane 5 of Figure 8C , the amount of AT NHK precipitated with OS-9 R188A was significantly decreased by approximately 6-fold compared to precipitation with wild-type OS-9. These results suggest that OS-9 interacts with AT NHK in a predominantly sugar-dependent manner, although it is not clear whether the association between AT NHK in AT and/or AT NHK and OS-9 (or OS-9 R188A )-expressing 293T cells was determined by Western blotting followed by staining with an anti-AT antibody. Proteins precipitated with FLAG-tagged OS-9/OS-9 R188A using an anti-FLAG antibody were identified by Western blotting followed by staining with anti-FLAG (B) or anti-AT (C) antibodies.
OS-9 and AT is a direct one or not. To clarify the sugar-binding dependence of the interaction between OS-9 and AT NHK , we expressed non-glycosylated variant of AT NHK (AT NHK -Q3) instead of AT NHK under the same condition described above and then immunoprecipitation experiment was performed. The result showed that the same amount of AT NHK -Q3 was precipitated with OS-9 (data not shown). This result was quite similar to those reported by Hosokawa et al. (2009) and it may suggest that OS-9 binds to the polypeptide in addition to sugar moieties. In another immunoprecipitation experiment, the lysate of the cells that had been transfected with AT NHK and FLAG-tagged OS-9 was treated with KIF, and then precipitated with an anti-FLAG monoclonal antibody, and stained with an anti-AT antibody under the same condition described above. The result showed that the amount of precipitated AT NHK was not so changed as that from untreated cells (data not shown). This result may support the idea indicating that OS-9 binds to the polypeptide in addition to sugar moieties, or because the effect of KIF may be partial, unaffected AT NHK was selectively precipitated with FLAG-tagged OS-9.
K Mikami et al. Fig. 9 . Two-dimensional electrophoresis of AT and AT NHK and GNA staining. Lysates prepared from AT and FLAG-tagged OS-9 co-expressing cells (A) and AT NHK and FLAG-tagged OS-9 co-expressing cells (B) were subjected to two-dimensional gel electrophoresis and then gels were stained with CBB. The dotted areas in A and B are enlarged in C and D, respectively. Lysate from AT, AT NHK , and FLAG-tagged OS-9 co-expressing cells was electrophoresed, blotted to a membrane, and then stained with GNA and the corresponding area is shown in E. AT and AT NHK were identified by Mascot analysis of their tryptic fragments using MALDI-TOF-MS (data not shown) and are indicated by white and black arrowheads, respectively.
To confirm that AT NHK , but not AT, contains smaller molecular-weight high-mannose-type glycans such as M5, M6, and M7, which we have shown to be suitable ligands for OS-9 (Figures 4 and 7) , we assessed sugar chains on AT and AT NHK for binding to Galanthus nivalis agglutinin (GNA). Previously, we demonstrated that GNA lectin specifically binds to the Manα1,6(Manα1,3)Man structure of high-mannose-type glycans and that substitution of nonreducing termini with α1,2-linked mannose abrogates that binding (Yamamoto et al. 2005) . Lysate from AT and FLAG-tagged OS-9 co-expressing cells and from AT NHK and FLAG-tagged OS-9 co-expressing cells was prepared under the same conditions as in the immunoprecipitation experiment, and was subjected to two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). AT, AT NHK , and other proteins were clearly separated in both their molecular weights and isoelectric points as shown in Figure 9A and B, respectively. Lysate from cells co-expressing AT, AT NHK , and FLAG-tagged OS-9 was electrophoresed under the same conditions, blotted onto a membrane, and then stained with GNA lectin. As shown in Figure 9E , GNA strongly bound to AT NHK but not to AT, indicating that AT NHK , but not AT, may have smaller molecular-weight high-mannose-type glycans without α1,2-linked mannose(s). Although we could not demonstrate that AT NHK precipitated with FLAG-tagged OS-9 bound to GNA due to the small amount of the sample, these results suggest that human OS-9 predominantly binds to AT NHK through smaller molecular-weight high-mannose-type glycans.
Discussion
Human OS-9 protein has a MRH domain which is homologous to the mannose 6-phosphate receptors (MPR). We expressed the soluble MRH domain of human OS-9 in E. coli and used it as a probe complexed with PE-labeled SA. When we made a tetramer of OS-9 MRH , it bound to the cell surface sugar chains of SW-treated HeLaS3 cells and Lec1 cells in a cation-independent manner. Although the MRH domain was determined to be a lectin domain homologous to a mannose 6-phosphate-binding unit in cation-dependent and independent MPRs, OS-9 MRH bound to mannose, but mannose 6-phosphate, mannose 1-phosphate, glucose 6-phosphate, and glucose 1-phosphate all failed to abrogate its binding to cells. Eight amino acid residues involved in mannose 6-phosphate-binding were identified by X-ray crystallographic analysis of the complexes of bovine CD-MPR and mannose 6-phosphate or pentamannosyl phosphate (Olson et al. 1999 ). The results indicate that the binding pocket for mannose 6-phosphate consists of two parts, one for Manα1,2Man and the other for a phosphate group. The Manα1,2Man-binding pocket comprises the Tyr45, Gln66, Arg111, Glu133, Arg135, and Tyr143 residues, and the phosphate-binding pocket comprises the Asp103, Asn104, and His105 residues. Sequence alignment of the MRH domains in the MPRs and human OS-9 using PSI-BLAST has shown that the distribution of cystines and 5 (Tyr45, Gln66, Arg111, Glu133, and Tyr143) of the 6-amino-acid residues involved in Manα1,2Man binding, but not in phosphate binding, was conserved in the MRH domain (Munro 2001) . This is in agreement with our result indicating that OS-9 MRH binds to mannose, but not mannose 6-phosphate, in a cation-independent manner. Furthermore, it is consistent with our finding that OS-9 MRH mutants with substitution of one of those five amino acids did not bind to sugars (Figure 5) .
We analyzed the sugar-binding specificity of OS-9 MRH by both an inhibition assay with several oligosaccharides and by frontal affinity chromatography using 92 different p-nitrophenyl (pNP)-derivatized glycans (0.5-8.0 mM) and 2-aminopyridine (PA)-labeled glycans. OS-9
MRH did not interact with either G1M9 or M9 high-mannose-type N-glycans. Our inhibition assay showed that OS-9 MRH is specific for the terminal Manα1,6Man sequence and that the branched pentamannoside (Manα1,3(Manα1,6)Manα1,6(Manα1,3)Man) was the most potent inhibitor among tested ones. Frontal affinity chromatography demonstrated that after cleavage of an α1,2-linked Man from the C-arm (Manα1,2Manα1,6Man) of M9, M8, M7, or M6 glycans, all of these bound strongly to OS-9 MRH . These results clearly indicate that the C-arm of high-mannose-type glycans is a critical determinant of OS-9 binding and that trimming of an outermost α1,2-linked mannose is essential for tight binding. These results are in agreement with a recent report on the sugar-binding specificity of yeast Yos9p (Quan et al. 2008) and human OS-9 (Hosokawa et al. 2009 ). However, slight differences in the specificity of human OS-9 compared to yeast Yos9p were found from our study (Figure 7) . Further trimming of an α1,6-linked mannose residue from the C-arm or an α1,3-linked mannose residue from the B-arm abrogated binding to human OS-9, which was not observed in Yos9p. This may be explained by differences in N-glycan processing, in which trimming of an α1,6-linked mannose residue from the C-arm and of an α1,3-linked mannose residue from the B-arm does not occur in yeast but is involved in the production of complex-type Nglycan in mammals. PE-labeled OS-9 MRH tetramer binding to HeLaS3 cell was enhanced when the cells were treated with KIF and DMJ, which are ER α-mannosidase I inhibitors (Figure 2A) . The treatment of the cells with KIF or DMJ seems to yield the Man 9 GlcNAc 2 structure, which acts as a poor ligand for OS-9 MRH , because ER α-mannosidase I, Golgi α-mannosidases IA, IB, and IC are sensitive to inhibition by KIF and DMJ (Lal et al. 1998; Tremblay and Herscovics 2000) . However, analysis of glycans displayed on the surface of HeLaS3 cells showed that complex-type glycans on the cell surface were decreased from 36.2% to 2.7%, and high-molecular-weight high-mannose-type glycans were increased from 30.7 to 69.6% after DMJ-treatment of the cell. Among these high-mannose-type glycans, M9, M8, and M7 glycans were included in relative quantity of 23.9, 30.3, and 15.4%, respectively ). This indicates that M8 and M7 high-mannose-type glycans were also present on the surface of the cell in addition to M9 glycans, which may act as good ligands for OS-9 MRH , since KIF and DMJ treatments may be insufficient for the action of other ER α-mannosidase II (Weng and Spiro 1996) . OS-9 is an ER-resident protein and the ligands for OS-9 are high-mannose-type glycans of smaller molecular weight. We sought to determine if these smaller high-mannose-type oligosaccharides are produced in the ER. In the ER, en bloc transfer of N-linked Glc 3 Man 9 GlcNAc 2 (G3M9) oligosaccharides to proteins is mediated by oligosaccharyltransferase, and further processing steps of the G3M9 sugar chains to Glc 2 Man 9 GlcNAc 2 (G2M9), Glc 1 Man 9 GlcNAc 2 (G1M9), and M9 take place successively through the action of the α-glucosidases I and II. M9 oligosaccharides are then digested to M8B by α1,2-specific ER α-mannosidase I, which cleaves one of the outermost mannoses on the B-arm but not the C-arm (Herscovics 2001) . Following transport to the Golgi complex, further trimming of α1,2-linked mannose residues results in the production of an M5 structure. Three subfamilies of mammalian class I α-mannosidases (family 47 glycosidases) have been identified: ER α-mannosidase I cleaves a single residue from M9 to generate the M8B structure, Golgi α-mannosidase I cleaves M9 and M8 structures to M5, and the EDEM1, 2, and 3 α-mannosidase-related proteins do not appear to have intrinsic hydrolase activity but appear to be required for ERAD. We incubated a mixture of PA-labeled M9 and purified Myc-tagged ER α-mannosidase I at 37
• C for 2 h and the M9 oligosaccharide was completely digested to M8B as determined by analysis with two-dimensional HPLC. However, additional digested products could not be found even when the incubation time was prolonged to 24 h (data not shown). This result indicates that no sugar ligands for OS-9 are produced by ER α-mannosidase I in the ER. We next set out to determine which of the α-mannosidases cleaves an outermost mannose on the C-arm. Herscovics et al. (2002) confirmed the specificity of human ER α-mannosidase I when a relatively low concentration of recombinant enzyme was incubated with M9, but M7 and M6 were also formed following a longer incubation with a much higher concentration of the enzyme in vitro. In addition, Avezov et al. (2008) have reported that ER α-mannosidase I was strongly concentrated together with the ERAD substrate in a specific cellular compartment known as the pericentriolar ER-derived quality control compartment (ERQC). These data suggest that N-glycans on misfolded glycoproteins may be more susceptible to removal of extra mannose residues by ER α-mannosidase I due to increased time spent in the ER. Another possibility is that EDEM1, 2, and/or 3 are candidates for further mannose trimming. Because EDEM1, 2, and 3 localize in the ER and have amino acid homology with the type I α-mannosidase family, PA-labeled M9 oligosaccharides were subjected to digestion with purified Myc-tagged EDEM1, 2, or 3 at 37
• C for 24 h. We found that M9 oligosaccharide was not cleaved at all under these conditions (data not shown). Incubation of M9 with a mixture of ER α-mannosidase I, and EDEM1, 2, and 3 resulted in the production of M8B, indicating that trimming of an outermost mannose from the C-arm may be mediated by another unknown α-mannosidase or that some other factors in the ER may participate in this reaction. There are some reports indicating that EDEM1 or EDEM3 can trim M9 and M8B high-mannose-type glycans to the lower M7, M6, and M5 species when cDNA encoding EDEM1 or EDEM3 is transfected into mammalian cells (Hirao et al. 2006; Olivari et al. 2006; Hosokawa et al. 2009 ) or yeast homolog Htm1p into yeast cells (Clerc et al. 2009 ), which seems to support the possibility that other ER factors participate in this reaction. Golgi α-mannosidase I (IA, IB, and IC) may be a candidate factor because it preferentially cleaves the Aand C-arms despite the similarity of its amino acid sequence and protein folding pattern to ER α-mannosidase I (Tempel et al. 2004; Hosokawa et al. 2007) . ER stress-induced property is also important to think about the candidates of the C-arm trimming α-mannosidase. Human EDEM1 (Hosokawa et al. 2001) and yeast Htm1p (Jakob et al. 2001 ) was found to be induced by ER stress but induction of other mammalian family 47 glycosidases has not been demonstrated yet. Other stress-induced proteins might participate in the trimming of α1,2-linked mannose on the C-arm indirectly by regulating α-mannosidase activity.
We performed a coprecipitation experiment with OS-9 using lysates from human α1-antitrypsin (AT)-and its variant null Hong Kong (AT NHK )-expressing cells. AT NHK is a wellcharacterized ERAD substrate and is translocated from the lumen of the ER to the cytoplasm (Sifers et al. 1988 ). Furthermore, depletion of OS-9 has been found to cause significant impairment of AT NHK clearance (Christianson et al. 2008 ). When we prepared cells expressing AT, AT NHK , and FLAGtagged OS-9, OS-9 specifically precipitated with AT NHK but not with AT ( Figure 8C ). This interaction between OS-9 and AT NHK in the ER seemed to occur in a sugar-dependent manner, because OS-9 mutants defective in sugar-binding activity showed less interaction with AT NHK ( Figure 8C , lanes 3 and 5). Because OS-9 localizes to the lumen of the ER, this result indicates that the ERAD substrate AT NHK , but not AT, can interact with OS-9 through sugar chains in the ER. This hypothesis is consistent with data showing that expression of AT NHK was increased in sugar-binding-deficient OS-9
R188A -expressing cells ( Figure 8A , lane 5) compared to wild-type OS-9-expressing cells ( Figure 8A , lane 3), based on the idea that wild-type OS-9 transfers the ERAD substrate to the downstream degradation machinery more efficiently. When we performed immunopreciptation experiment using the lysate expressing AT and FLAG-tagged OS-9 cells after 20 h treatment of SW, OS-9 did not precipitated with AT (data not shown). This result indicated that ER-resident OS-9 could not interact with Golgi-resident AT having GlcNAcMan 5 GlcNAc 2 sugar chains localizes.
In contrast, part of the interaction between OS-9 and AT NHK seems not to be mediated by sugar chains attached to AT NHK because a small amount of AT NHK was coprecipitated with sugarbinding-deficient OS-9 R188A ( Figure 8C ). This was supported by the data showing that AT NHK -Q3 was precipitated with OS-9 (data not shown). Recently, this same sugar-independent interaction of OS-9 and AT NHK was reported (Bernasconi et al. 2008 ). Furthermore, Christianson et al. (2008) found that OS-9 can interact with GRP94, a chaperone of the ER-resident Hsp90 paralog together with SEL1L, a component of an ER-multiprotein complex implicated in the process of recognition and/or dislocation of misfolded proteins. Because OS-9 binds to GRP94 in a sugar-independent manner, the sugar-independent interaction of OS-9 (and sugar-binding-deficient OS-9 R188A ) and AT NHK detected in our experiment may be indirect (i.e. OS-9 may bind to AT NHK through GRP94). Binding of OS-9 to AT NHK predominantly occurs in a sugardependent manner, as seen from the OS-9 sugar-binding specificity shown in Figure 7 , indicating that AT NHK has sugar chains from which an outermost mannose is trimmed on the C-arm. We analyzed the sugar structures attached to AT and AT NHK using GNA lectin, which has a specific affinity for the Manα1,6(Manα1,3)Man structure of high-mannose-type glycans. Our GNA staining data suggests that AT NHK , but not AT, has smaller molecular weight high-mannose-type glycans. The isoelectric points of AT and AT NHK were approximately 5.7 and were different from those of secreted AT that has sialylated glycans (Kolarich et al. 2006) , indicating that most of the AT and AT NHK analyzed by 2D-PAGE is localized to the ER.
As discussed above, ER-resident EDEM1, 2, and 3, and α-mannosidase I are the most likely candidates for enzyme processing of the sugar chains of AT NHK (but not AT). Golgiresident α-mannosidases are also possible candidates for this processing if the ERAD substrate AT NHK is recycled from the Golgi to the ER. It has been reported that these types of recycled glycoproteins are destined for ERAD (Hammond et al. 1994) . Previously, we reported that the cargo receptor VIP36 bound strongly to the intact A-arm of high-mannose-type glycans with a Manα1,2Manα1,2Man sequence ) and that VIP36 interacted with the chaperone BiP specifically in the ER . Glycoproteins retrotransported by VIP36 might be a substrate for ERAD, although VIP36 seems to have no ability to distinguish correctly folded glycoproteins from misfolded ones. In order to understand the ERAD substrate specificity in cells, it is important to identify the ERAD substrate-recognizing α-mannosidases and other factors associated with these enzymes in the ER. After digestion with α-mannosidases, ERAD substrates may be recognized by OS-9 and guided to an ER membrane-embedded translocon complexed with ubiquitin ligase. Table I . Primers used in site-directed mutagenesis OS-9 Y120A(F) 5 -gacaaaggactggtggacagctgaattctgttatggacgc-3 OS-9 Y120A(R) 5 -gcgtccataacagaattcagctgtccaccagtcctttgtc-3 OS-9 Q130E(F) 5 -atggacgccacatccaggaataccacatggaagat-3 OS-9 Q130E(R) 5 -atcttccatgtggtattcctggatgtggcgtccat-3 OS-9 H132A(F) 5 -cgccacatccagcaatacgccatggaagattcagagat-3 OS-9 H132A(R) 5 -atctctgaatcttccatggcgtattgctggatgtggcg-3 OS-9 R188A(F) 5 -gaccttaatgggaggcccgcggaggccgaggttcggtt-3 OS-9 R188A(R) 5 -aaccgaacctcggcctccgcgggcctcccattaaggtc-3 OS-9 E212D(F) 5 -Atcgcgtggacgaccccttgtcctgct-3 OS-9 E212D(R) 5 -agcaggacaaggggtcgtccacgcgat-3 OS-9 Y218F(F) 5 -gcccttgtcctgctcttttgtgctgaccattcgca-3 OS-9 Y218F(R) 5 -tgcgaatggtcagcacaaaagagcaggacaagggc-3 (F) and (R) indicate forward and reverse primers, respectively.
Material and methods
Cell culture
Human cervical adenocarcinoma HeLaS3 cells and Chinese hamster ovary (CHO) cells were maintained in RPMI1640 (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heatinactivated fetal calf serum (Intergen, New York), penicillin (100 U/mL)-streptomycin (100 μg/mL), 2 mM glutamine, and 50 μM 2-mercaptoethanol. Lectin-resistant CHO cell lines (Lec1, Lec2, and Lec8) were maintained in α-modified MEM (Sigma) with 10% heat-inactivated fetal calf serum (Intergen), penicillin (100 U/mL)-streptomycin (100 μg/mL), 2 mM glutamine, and 50 μM 2-mercaptoethanol.
Construction of plasmids for the OS-9 soluble MRH domain (OS-9
MRH ) and mutants cDNA encoding human OS-9 was prepared as described previously (Kimura et al. 1997 (Kimura et al. , 1998 . To express OS-9 MRH , residues 241-711 were amplified by PCR using the primers 5 -agcatatgcacttccagcgtgaaaggg-3 and 5 -ctagtactgggtgggggccgga-3 , which contain restriction sites for Nde I and Sca I, respectively (shown italicized). The amplified DNA was inserted between the Sma I sites of the pBluescript SK II (+) vector. Because OS-9 MRH cDNA contains a restriction site for Nde I, an adenine at residue 357 was replaced with thymine by PCR-based mutagenesis using a Quickchange II site-directed mutagenesis kit (Stratagene, La Jolla, CA) and the mutated primers 5 -aaaggactggtggacttatgaattctgttat-3 and 5 -ataacagaattcataagtccaccagtccttt-3 . pBluescript SK II(+)-OS-9 MRH was digested with Nde I and Sca I and then inserted between the Sma I sites of the pET3c-Cbio expression vector to fuse the recombinant protein to an enzymatic biotinylation tag at the C-terminus. OS-9
MRH clones containing the following mutations, Y120A, Q130E, H132A, R188A, E212D, and Y218F, were also generated by PCR-based mutagenesis using a Quickchange II site-directed mutagenesis kit and the forward and reverse primers listed in Table I .
Preparation of biotinylated recombinant soluble OS-9
MRH protein and mutants OS-9 MRH and its mutants were expressed in the BL21(DE3)pLysS strain of E. coli in the presence of 1 mM isopropyl β-thiogalactopyranoside and were recovered as inclusion bodies. The inclusion bodies were solubilized in the solubilization buffer (50 mM Tris-HCl, pH 8.0, containing
